Literature DB >> 31548191

Injectable opioid agonist treatment for opioid use disorder: a national clinical guideline.

Nadia Fairbairn1, Josey Ross2, Michael Trew2, Karine Meador2, Jeff Turnbull2, Scott MacDonald2, Eugenia Oviedo-Joekes2, Bernard Le Foll2, Marie-Ève Goyer2, Michel Perreault2, Christy Sutherland2.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 31548191      PMCID： PMC6763328          DOI： 10.1503/cmaj.190344

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  29 in total

Review 1.  Heroin maintenance for chronic heroin-dependent individuals.

Authors:  Marica Ferri; Marina Davoli; Carlo A Perucci
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

2.  Quality of life under maintenance treatment with heroin versus methadone in patients with opioid dependence.

Authors:  A Karow; J Reimer; I Schäfer; M Krausz; C Haasen; U Verthein
Journal:  Drug Alcohol Depend       Date:  2010-08-21       Impact factor: 4.492

3.  Guidelines International Network: Principles for Disclosure of Interests and Management of Conflicts in Guidelines.

Authors:  Holger J Schünemann; Lubna A Al-Ansary; Frode Forland; Sonja Kersten; Jorma Komulainen; Ina B Kopp; Fergus Macbeth; Susan M Phillips; Craig Robbins; Philip van der Wees; Amir Qaseem
Journal:  Ann Intern Med       Date:  2015-10-06       Impact factor: 25.391

4.  Effect of Buprenorphine Implants on Illicit Opioid Use Among Abstinent Adults With Opioid Dependence Treated With Sublingual Buprenorphine: A Randomized Clinical Trial.

Authors:  Richard N Rosenthal; Michelle R Lofwall; Sonnie Kim; Michael Chen; Katherine L Beebe; Frank J Vocci
Journal:  JAMA       Date:  2016-07-19       Impact factor: 56.272

5.  Loss of treatment benefit when heroin-assisted treatment is stopped after 12 months.

Authors:  Isabelle Demaret; Etienne Quertemont; Géraldine Litran; Cécile Magoga; Clémence Deblire; Nathalie Dubois; Corinne Charlier; André Lemaitre; Marc Ansseau
Journal:  J Subst Abuse Treat       Date:  2016-06-16

6.  The impact of buprenorphine on treatment of opioid dependence in a Medicaid population: recent service utilization trends in the use of buprenorphine and methadone.

Authors:  Bradley D Stein; Adam J Gordon; Mark Sorbero; Andrew W Dick; James Schuster; Carrie Farmer
Journal:  Drug Alcohol Depend       Date:  2011-11-16       Impact factor: 4.492

7.  Diacetylmorphine versus methadone for the treatment of opioid addiction.

Authors:  Eugenia Oviedo-Joekes; Suzanne Brissette; David C Marsh; Pierre Lauzon; Daphne Guh; Aslam Anis; Martin T Schechter
Journal:  N Engl J Med       Date:  2009-08-20       Impact factor: 91.245

Review 8.  Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.

Authors:  Richard P Mattick; Courtney Breen; Jo Kimber; Marina Davoli
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

9.  Telling our stories: heroin-assisted treatment and SNAP activism in the Downtown Eastside of Vancouver.

Authors:  Susan Boyd; Dave Murray; Donald MacPherson
Journal:  Harm Reduct J       Date:  2017-05-18

10.  The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines.

Authors:  Melissa C Brouwers; Kate Kerkvliet; Karen Spithoff
Journal:  BMJ       Date:  2016-03-08
View more
  18 in total

1. 

Authors:  Kevin Pottie; Claire E Kendall; Tim Aubry; Olivia Magwood; Anne Andermann; Ginetta Salvalaggio; David Ponka; Gary Bloch; Vanessa Brcic; Eric Agbata; Kednapa Thavorn; Terry Hannigan; Andrew Bond; Susan Crouse; Ritika Goel; Esther Shoemaker; Jean Zhuo Jing Wang; Sebastian Mott; Harneel Kaur; Christine Mathew; Syeda Shanza Hashmi; Ammar Saad; Thomas Piggott; Neil Arya; Nicole Kozloff; Michaela Beder; Dale Guenter; Wendy Muckle; Stephen Hwang; Vicky Stergiopoulos; Peter Tugwell
Journal:  CMAJ       Date:  2020-10-13       Impact factor: 8.262

2.  Motivations to initiate injectable hydromorphone and diacetylmorphine treatment: A qualitative study of patient experiences in Vancouver, Canada.

Authors:  Samara Mayer; Al Fowler; Isabella Brohman; Nadia Fairbairn; Jade Boyd; Thomas Kerr; Ryan McNeil
Journal:  Int J Drug Policy       Date:  2020-09-16

3.  Outcomes of Ottawa, Canada's Managed Opioid Program (MOP) where supervised injectable hydromorphone was paired with assisted housing.

Authors:  Miriam Th Harris; Rebecca K Seliga; Nadia Fairbairn; Seonaid Nolan; Alexander Y Walley; Zoe M Weinstein; Jeffery Turnbull
Journal:  Int J Drug Policy       Date:  2021-08-30

4.  The need to prioritize research, policy, and practice to address the overdose epidemic in smaller settings in Canada.

Authors:  Geoff Bardwell; Leslie Lappalainen
Journal:  Can J Public Health       Date:  2021-03-29

5.  Barriers and facilitators to a novel low-barrier hydromorphone distribution program in Vancouver, Canada: a qualitative study.

Authors:  Andrew Ivsins; Jade Boyd; Samara Mayer; Alexandra Collins; Christy Sutherland; Thomas Kerr; Ryan McNeil
Journal:  Drug Alcohol Depend       Date:  2020-09-15       Impact factor: 4.492

6.  Increasing preference for fentanyl among a cohort of people who use opioids in Vancouver, Canada, 2017-2018.

Authors:  Sarah Ickowicz; Thomas Kerr; Cameron Grant; M-J Milloy; Evan Wood; Kanna Hayashi
Journal:  Subst Abus       Date:  2021-07-20       Impact factor: 3.716

7.  Hospital Initiated Injectable Opioid Agonist Therapy for the Treatment of Severe Opioid Use Disorder: A Case Series.

Authors:  Rupinder Brar; Nadia Fairbairn; Kate Colizza; Andrea Ryan; Seonaid Nolan
Journal:  J Addict Med       Date:  2021-04-01       Impact factor: 4.647

8.  Building healthcare provider relationships for patient-centered care: A qualitative study of the experiences of people receiving injectable opioid agonist treatment.

Authors:  Kirsten Marchand; Julie Foreman; Scott MacDonald; Scott Harrison; Martin T Schechter; Eugenia Oviedo-Joekes
Journal:  Subst Abuse Treat Prev Policy       Date:  2020-01-20

9.  The effectiveness of substance use interventions for homeless and vulnerably housed persons:  A systematic review of systematic reviews on supervised consumption facilities, managed alcohol programs, and pharmacological agents for opioid use disorder.

Authors:  Olivia Magwood; Ginetta Salvalaggio; Michaela Beder; Claire Kendall; Victoire Kpade; Wahab Daghmach; Gilbert Habonimana; Zack Marshall; Ellen Snyder; Tim O'Shea; Robin Lennox; Helen Hsu; Peter Tugwell; Kevin Pottie
Journal:  PLoS One       Date:  2020-01-16       Impact factor: 3.240

10.  Expanding Access to Medications for Opioid Use Disorder: Program and Policy Approaches from Outside the Veterans Health Administration.

Authors:  Kelsey C Priest; Dennis McCarty; Travis I Lovejoy
Journal:  J Gen Intern Med       Date:  2020-11-03       Impact factor: 5.128
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.